Business Context and Reporting Period
This Form 8-K Current Report was filed by Autonomix Medical, Inc. (AMIX) on July 28, 2026. The report addresses "Other Events" under Item 8.01, specifically updating the company's cash position and outstanding share count following a recent warrant inducement.
Key Financial Metrics
- Cash Balance: Approximately $5.1 million as of July 28, 2026.
- Shares Outstanding: 971,043 shares of common stock.
- Recent Capital Activity: The share count includes shares issued as part of a warrant inducement executed on July 13, 2026.
- Revenue, Profit, and Margins: The filing text does not provide a clear value for revenue, profit, cash flow, or margins.
- Debt and Liquidity: Beyond the stated cash balance, the filing text does not provide a clear value for debt levels or other liquidity metrics.
Material Changes
The primary material change disclosed is the increase in outstanding shares to 971,043 due to the warrant inducement completed on July 13, 2026. The filing does not provide comparative data to quantify changes in cash or share count versus prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the disclosure of the current capital structure. No unusual items or contingencies were detailed in this report.
Investor Verification Checklist
- Verify the terms and dilution impact of the warrant inducement executed on July 13, 2026.
- Confirm the company's burn rate and runway given the $5.1 million cash balance.
- Review recent 10-Q or 10-K filings for historical revenue and expense data not included in this 8-K.
- Check for any subsequent filings regarding additional capital raises or debt obligations.